Category: Federal Circuit
-
Canadian Solar, Maxeon settle U.S. patent dispute
The Eastern District of Texas has dismissed Maxeon’s suit against Canadian Solar with prejudice, while the Federal Circuit has vacated the relevant portion of a PTAB decision relating to Maxeon’s remaining claim, resolving the case in Canadian Solar’s favor.
-
Federal Circuit affirms invalidation of Nielsen’s audience-measurement patent, backs PTAB’s “reasonably pertinent” prior art finding
The Federal Circuit affirmed a PTAB ruling invalidating Nielsen’s audience-measurement patent, holding that a facial-expression research paper qualified as “reasonably pertinent” prior art despite coming from a different research field.
-
Dental AI patent still has teeth after Federal Circuit vacates decision that saw PTAB side with Invisalign maker
The appeals court found that the PTAB erred in recognizing as prior art an application claiming a priority date from a provisional filing.
-
Federal Circuit restates eBay’s end to presumption of irreparable harm, as it vacates preliminary injunction over means-plus-function claim
Socket Solutions had obtained the injunction in district court; but that court’s claim construction was rejected on appeal.
-
Federal Circuit affirms PTAB invalidation of G+ Communications 5G patent, leaving Samsung’s damages cut intact
The Federal Circuit has affirmed a Patent Trial and Appeal Board ruling invalidating one of two 5G patents G+ Communications asserted against Samsung, closing off G+’s last chance to revive that patent.
-
Federal Circuit upholds decision to throw out $107.5M patent infringement verdict against AstraZeneca
The precedential decision, confirming the invalidation of two of Pfizer subsidiary Wyeth’s cancer drug-related patents, held that the plaintiff not only failed to rebut evidence on certain issues, but its own experts agreed against it.
-
Federal Circuit applies Third Circuit law to vacate District of Delaware’s waiver of preliminary injunction bond
The district court made the rare decision to waive Otsuka Pharmaceutical’s requirement to post a bond after granting it a preliminary injunction against Hetero Labs’ generic competitor.
-
U.S. Supreme Court denies Finesse Wireless cert petition, snuffs out $166M verdict against AT&T
After an Eastern District of Texas jury awarded substantial damages to Finesse in 2023, AT&T and intervenor Nokia successfully appealed to the Federal Circuit.
-
FTC urges Fourth Circuit to reverse summary judgment for Johnson & Johnson in Stelara antitrust suit: ‘specific intent not required to prove monopolization’
The U.S. Federal Trade Commission has told the Fourth Circuit that a Virginia court wrongly required proof of specific intent before CareFirst’s Stelara biosimilar-patent monopoly claims against Johnson & Johnson could proceed.
-
Lessons for prior art search providers as Federal Circuit again sides with Valve in appeal over game controller patent
“Something more is required” for estoppel when a classification search returns tens of thousands of results; while forward-and-backward citation searches may result in hindsight bias.